Independent biostatistical, statistical programming, and data science consulting. Contact me if you have an interesting project you need help with!

Danielle Beaulieu, M.P.H., joined Statistics Collaborative, Inc. (SCI) in 2009. She is a member of the Society for Clinical Trials.Ms. Beaulieu joined SCI as a Research Assistant, providing support to project teams on clinical trials in a range of areas, including treatments for cardiovascular disease, thyroid cancer, active acromegaly, and age-related macular degeneration, as well as trials of malaria vaccines. She assisted project managers in preparing safety monitoring reports for Data Monitoring Committees (DMCs), designing table and figure shells, and managing communications with DMC members and sponsor teams. As she gained experience, Ms. Beaulieu took on a larger coordination role on her projects, learned SAS programming in order to develop and validate datasets and presentations, and pursued her graduate degree.As a Biostatistician, Ms. Beaulieu provides statistical support and coordination for projects spanning the areas of cardiovascular disease, infectious disease, metabolic disorders, and oncology. She programs datasets and statistical analyses, validates SAS program code, assists in the development of statistical analysis plans, and participates in writing study reports. In collaboration with senior statisticians and programmers, Ms. Beaulieu also contributed to the development of SCI’s internal training materials on SAS programming for new employees.Ms. Beaulieu received her B.A. magna cum laude in Mathematics and Biostatistics with a minor in Psychology from Emmanuel College (2008) and her M.P.H. in Epidemiology from The George Washington University (2014). Her master’s project was titled “Geospatial patterns of breast cancer treatment delay disparities in the District of Columbia”.

Statistical programmer and project coordinator for a large Phase 3 outcomes study of a novel cardiovascular agent (2012–), a Phase 1 malaria vaccine trial (2014–), trials investigating therapies for patients with pulmonary arterial hypertension (2014–), and squamous cell carcinoma of the head and neck (2014–)Statistical programmer and project coordinator for NIH funded trial investigating prophylaxis use in HIV+ patients receiving ART (2012–)Statistical programmer for trials investigating therapies for patients with chronic kidney disease and type 2 diabetes (2012–), a recent acute coronary syndrome and type 2 diabetes (2011–), and breast cancer (2012–)Worked to develop a program training manual to be used in the training of new staff in SAS and SCI specific programming procedures and guidelines (2012–2013)

Programmer working on the Institute of Medicine’s Congressionally-mandated study to evaluate programs implemented under the Tom Lantos and Henry J. Hyde U.S. Global Leadership Against HIV/AIDS, Tuberculosis, and Malaria Reauthorization Act of 2008 (2011–) Research assistant (2009-2010), programmer (2009-), and project coordinator (2011-) for a large industry sponsored development program including Phase 2, 3, and 3b Data Monitoring Committee trials investigating a novel cardiovascular agent.Programmer for trials investigating therapies for patients with prostate cancer (2009-2011), Hepatitis C (2010- ), and Type 2 diabetes (2010- )Programmer for trial investigating vaccine for HAC1 influenza (2010-2011)Assisted with CRF and database development for Phase 1/2a studies of malaria vaccines (2010-2011)Informal training and supervision of new staff (2010)Programmer for multi-reader, multi-case studies investigating mammography systems (2009-2011)Programmer for a study of parental decision and adolescent assent in clinical research (2009) Research associate and programmer for Phase 3 DMC trials investigating therapies for patients with thyroid carcinoma (2009-2010), active acromegaly (2009-2011), and age related macular degeneration (2009-2011).